Surgical Robots Market Global Report 2026

The surgical robots market size has grown exponentially in recent years. It will grow from $11.2 billion in 2025 to $13.69 billion in 2026 at a compound annual growth rate (CAGR) of 22.2%. The growth in the historic period can be attributed to increasing demand for minimally invasive procedures, expansion of specialty surgical practices, rising surgeon preference for robotic assistance, availability of advanced imaging technologies, and growth in hospital surgical capacity.

The surgical robots market size is expected to see exponential growth in the next few years. It will grow to $30.09 billion in 2030 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to increasing investments in robotic surgery platforms, rising adoption across new surgical specialties, expansion of outpatient robotic procedures, growing focus on surgical precision and safety, and increasing integration of digital surgery ecosystems. Major trends in the forecast period include increasing adoption of robot-assisted minimally invasive surgery, rising integration of AI-guided surgical systems, growing use of advanced imaging and visualization technologies, expansion of modular and specialty surgical robots, and greater emphasis on precision and patient outcomes.

The increasing elderly and surgical patient populations are expected to propel the growth of the surgical robot market in the coming years. The growing elderly and surgical patient populations have a significant impact on the use and development of surgical robots. Minimally invasive procedures performed by surgical robots help reduce patient trauma, shorten recovery times, and lower complication rates. These benefits are particularly important for older people as they help reduce mortality and morbidity rates. For instance, according to the World Health Organization (WHO), a Switzerland-based Intergovernmental organization, 1 in 6 people globally will be aged 60 or older by 2030, with the population in this age group expected to increase from 1 billion in 2020 to 1.4 billion by 2030, and further double to 2.1 billion by 2050. Moreover, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, in 2023, the total number of surgical and non-surgical treatments increased to 34.9 million, representing a 3.4% rise. Therefore, the increasing elderly and surgical patient populations are driving the surgical robot market.

Major companies operating in the surgical robot market are focusing on developing advanced technologies such as robotic platforms to expand their customer base, increase sales, and generate higher revenue. A robotic platform refers to a physical or virtual infrastructure that provides a foundation for the operation and integration of robotic systems. For instance, in May 2023, Robocath, a France-based medical robotics company, launched R-One+ for coronary angioplasties. The distinctive feature of the R-One+ robotic solution is its ability to reduce radiation-induced injuries while improving the safety and ease of medical procedures. This innovative technology enables interventional cardiologists to perform coronary angioplasties by maneuvering devices through an integrated control command unit located either in the cath lab or the control room. This dual functionality provides two key advantages. First, it protects the cardiologist and medical team from radiation-induced injuries, and second, it makes the percutaneous coronary intervention (PCI) procedure more streamlined and secure. The R-One+ enables cardiologists to perform refined hand movements with greater precision, creating a more comfortable working environment and ultimately improving patient outcomes.

In February 2023, ARCH Medical Solutions Corp., a US-based company combining engineering expertise and precision-machining technologies, acquired Bettanini's Custom Manufacturing for an undisclosed amount. The acquisition strengthens and expands ARCH Medical Solutions Corp.’s offerings and capabilities to provide industry-leading OEMs with precision manufacturing solutions. Bettanini's Custom Manufacturing is a US-based manufacturer of precision-machined components, including components for surgical robots.

Major companies operating in the surgical robots market are Stryker Corporation, Medrobotics Corporation, Smith & Nephew plc, TransEnterix Inc., Renishaw plc, Intuitive Surgical Inc., Medtronic plc, THINK Surgical Inc., Zimmer Biomet Holdings Inc., Johnson & Johnson, Titan Medical Inc., Mazor Robotics Ltd., KUKA Aktiengesellschaft, Avatera Medical GmbH, Corindus Vascular Robotics Inc., MicroSure (Pty) Ltd, Asensus Surgical Inc., Siemens Healthcare GmbH, CMR Surgical Ltd., Auris Health Inc., Verb Surgical Inc., OMNIlife Science Inc., Vicarious Surgical Inc., Microbot Medical Inc., Virtual Incision Corporation, Memic Innovative Surgery Ltd., XACT Robotics Ltd., EndoMaster Pte. Ltd., MST Medical Surgery Technologies Ltd., Medtech SA.

North America was the largest region in the surgical robots market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global surgical robots market report forecast period. The regions covered in the surgical robots market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the surgical robots market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 1-3 business days.